The Landscape is a database that compiles and summarizes publicly available information on the global R&D pipeline of universal, broadly protective, and next-generation influenza vaccine candidates, as defined in the Influenza Vaccines R&D Roadmap (IVR). Vaccine candidates profiled in the Landscape are designed to provide broader and more durable protection against seasonal and pandemic influenza, compared with current strain-specific influenza vaccines.
CIDRAP initiated development of the Landscape with support from the Global Funders Consortium for Universal Influenza Vaccine Development (2019-2024) and currently receives support from the Collaborative Influenza Vaccine Innovation Centers (CIVICs), US National Institute of Allergy and Infectious Diseases (NIAID).
Database last updated on Dec 4, 2024
Database
Preclinical
|
Phase 1
|
Phase 2
|
Phase 3
|
Approved
|
---|---|---|---|---|
Platform
Influenza virus-based |
||||
16
Vaccines in
Preclinical
|
2
Vaccines in
Phase 1
|
3
Vaccines in
Phase 2
|
0
Vaccines in
Phase 3
|
0
Vaccines in
Approved
|
|
|
|
|
|
Platform
Nucleic acid-based |
||||
34
Vaccines in
Preclinical
|
6
Vaccines in
Phase 1
|
5
Vaccines in
Phase 2
|
4
Vaccines in
Phase 3
|
0
Vaccines in
Approved
|
|
|
|
|
|
Platform
Non-VLP nanoparticles |
||||
44
Vaccines in
Preclinical
|
4
Vaccines in
Phase 1
|
1
Vaccines in
Phase 2
|
2
Vaccines in
Phase 3
|
0
Vaccines in
Approved
|
|